Brussels, 27/02/2015 (Agence Europe) - The Court of Justice of the EU ruled on Thursday 26 February that the decision limiting reimbursement of the medicine Protelos (produced by the Servier laboratory) to a certain category of patient does not meet the duty to provide an explanation required by EU law (case C-691/13).
The Servier laboratory markets a medicine in France, Protelos, for the treatment of osteoporosis in menopausal women. In 2011, the French authorities took the view that...